Royalty Pharma plc
110 East 59th Street,
New York, 10022, NY,
United States
New York, 10022, NY,
United States
1 914-207-2300
Life Sciences
Royalty Pharma plc Technographics
Royalty Pharma plc Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Royalty Pharma plc and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 60 Royalty Pharma plc employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Royalty Pharma plc has purchased the following applications: Microsoft 365 for Collaboration in 2015, Adobe Experience Cloud for Customer Experience in 2021, New Relic APM for Application Performance Management in 2020 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Royalty Pharma plc is running and its propensity to invest more and deepen its relationship with Microsoft , Adobe Systems , Salesforce or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Royalty Pharma plc revenues, which have grown to $4.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Royalty Pharma plc intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Royalty Pharma plc Tech Stack and Enterprise Applications
Royalty Pharma plc Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 Royalty Pharma plc deployed Microsoft 365 as its primary Collaboration platform. Microsoft 365 is referenced on Royalty Pharma's public website and is provisioned to support core corporate collaboration functions including email, document sharing, synchronous and asynchronous communications, and external stakeholder engagement.
The deployment follows a cloud-hosted Microsoft 365 tenant architecture, leveraging standard Collaboration capabilities such as Exchange Online for mail, SharePoint and OneDrive for content management, and Teams for meetings and chat. Administration and tenant governance are centralized to support a company-wide rollout across corporate staff, with configuration focused on productivity workflows, records retention, and controls for external collaboration. Royalty Pharma plc Microsoft 365 Collaboration supports business functions for corporate communications, knowledge management, and investor relations workflows.
|
Royalty Pharma plc CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Adobe Systems | Legacy | Adobe Experience Cloud | Customer Experience | CRM | n/a | 2021 | 2021 |
In 2021, Royalty Pharma plc implemented Adobe Experience Cloud on their website, adopting the Customer Experience platform for web-facing digital experience management. The deployment is focused on the corporate web property, providing a centralized experience delivery layer and visitor analytics for marketing and communications use cases.
The implementation leverages content management, digital asset orchestration, analytics and personalization capabilities that are typical of Adobe Experience Cloud, enabling editorial workflows, experience testing and tag management for the site. Operational coverage centers on web content operations and marketing communications, with governance structured around editorial approval workflows and analytics instrumentation to support content publishing and iterative experience optimization.
|
|
|
|
|
Data Management Platform | CRM |
|
2022 | 2022 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2021 | 2021 |
|
|
|
|
|
Marketing Automation | CRM |
|
2020 | 2020 |
|
|
|
|
|
Marketing Automation | CRM |
|
2022 | 2022 |
|
|
|
|
|
Marketing Automation | CRM |
|
2022 | 2022 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
|
|
|
|
Tag Management | CRM |
|
2021 | 2021 |
|
Royalty Pharma plc ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| New Relic | Legacy | New Relic APM | Application Performance Management | ITSM | n/a | 2020 | 2020 |
In 2020, Royalty Pharma plc instrumented its public website with New Relic APM to introduce Application Performance Management and improve visibility into web application behavior. The deployment uses New Relic APM agent-based instrumentation to collect transaction traces, throughput, response time and error metrics, aggregating telemetry into centralized New Relic APM dashboards for continuous observability.
Configuration emphasizes real time observability, alerting and trace-level diagnostics consistent with Application Performance Management practices, enabling structured incident triage and diagnostics workflows. The implementation is scoped to the public website and associated web application tiers, supporting engineering and digital operations teams, with governance practices focused on instrumentation ownership, alert threshold configuration and incident escalation procedures.
|
Royalty Pharma plc Investment Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Investment Research and Market Intelligence | Investment Management |
|
2025 | 2025 |
|
|
|
|
|
Investment Research and Market Intelligence | Investment Management |
|
2025 | 2025 |
|
Royalty Pharma plc IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2015 | 2015 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
Royalty Pharma plc CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs), Archive as a Service (AaaS) | CyberSecurity |
|
2017 | 2017 |
|
Royalty Pharma plc Internet of Things
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
IoT Platform | Internet of Things |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Royalty Pharma plc
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Royalty Pharma plc Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Royalty Pharma plc IT executives and key decision makers. This section highlights Royalty Pharma plc's latest recorded technology evaluations, including Sterling Background Check for BackGround Screening on 2025-08-05. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Royalty Pharma plc digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| 2025-08-05 | Royalty Pharma plc | Evaluated | Sterling Talent Solutions | Sterling Background Check | BackGround Screening | HCM |
FAQ - APPS RUN THE WORLD Royalty Pharma plc Technographics
Royalty Pharma plc is a Life Sciences organization based in United States,
with around 60 employees and annual revenues of $4.0 million.
Royalty Pharma plc operates a diverse technology stack with applications such as
Microsoft 365, Adobe Experience Cloud and New Relic APM,
covering areas like Collaboration, Customer Experience and Application Performance Management.
Royalty Pharma plc has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Microsoft, Adobe Systems and New Relic.
Royalty Pharma plc recently adopted applications including
Alpha Sense Sentieo Data Terminal in 2025, AlphaSense Wall Street Insights in 2025 and Adobe Audience Manager in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Royalty Pharma plc’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Royalty Pharma plc’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Royalty Pharma plc technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.